Article Text

Download PDFPDF
A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease
  1. P Riley1,
  2. J O’Donohue1,
  3. M Crook2
  1. 1
    Department of Gastroenterology, University Hospital Lewisham, London, UK
  2. 2
    Department of Biochemistry, University Hospital Lewisham, London, UK
  1. Mr P Riley, Department of Gastroenterology, University Hospital Lewisham, Lewisham High Street, London SE13 6LH, UK; paul.riley{at}


Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic disorder in western countries, and its incidence is increasing. This review outlines the significant health burden posed by NAFLD and discusses what is presently known about its pathogenesis, including the roles of the metabolic syndrome, obesity, insulin resistance, hepatic steatosis, reactive oxygen species, inflammatory cytokines and adipocytokines. The way in which NAFLD is clinically diagnosed is described, and areas of uncertainty surrounding its investigation are identified, before discussing the relative merits of the limited treatment options available and looking ahead to potential therapeutic strategies for the future.

Statistics from


  • Competing interests: None.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.